SCHEMBL28801639

SCHEMBL28801639

CN1C(=O)COc2ccc(-c3ccc([C]=O)cc3)cc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 2/20 0.54
PDE3A Q14432 2/20 0.54
CYP11B1 P15538 1/20 0.47
CYP11B2 P19099 1/20 0.47
GPR55 Q9Y2T6 1/20 0.47
CTSC P53634 1/20 0.42
BRD4 O60885 4/20 0.40
GRM4 Q14833 1/20 0.39
USP30 Q70CQ3 1/20 0.39
ALOX5 P09917 1/20 0.38
HTT P42858 2/20 0.38
PTGER3 P43115 1/20 0.37
HTR1A P08908 2/20 0.36
DRD2 P14416 1/20 0.36
HTR2A P28223 1/20 0.36
TSHR P16473 1/20 0.36
HTR1D P28221 1/20 0.35
HTR1B P28222 1/20 0.35
SLC6A4 P31645 1/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10163703 0.78 PDE3B (0.48) PDE3BPDE3ACYP11B1CYP11B2GPR55
SCHEMBL280110 0.74 TSHR (0.58) PDE3BPDE3AHTTTSHR
SCHEMBL26034093 0.74 PDE3B (0.49) PDE3BPDE3ACYP11B1CYP11B2GPR55
SCHEMBL9467658 0.73 PDE3B (0.51) PDE3BPDE3ACYP11B1CYP11B2GPR55
SCHEMBL3332098 0.73 PDE3B (0.51) PDE3BPDE3ACYP11B1CYP11B2GPR55
SCHEMBL13780087 0.73 KMO (0.58) PDE3BPDE3AHTTTSHR
SCHEMBL265087 0.73 PDE3B (0.54) PDE3BPDE3ACYP11B1CYP11B2GPR55
SCHEMBL653919 0.73 PDE3B (0.51) PDE3BPDE3ACYP11B1CYP11B2GPR55
SCHEMBL993713 0.73 PDE3B (0.51) PDE3BPDE3ACYP11B1CYP11B2GPR55
SCHEMBL30991588 0.73 PDE3B (0.51) PDE3BPDE3ACYP11B1CYP11B2GPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103003233-A Novel hydroxamic acid derivative TAISHO PHARMACEUTICAL CO LTD 2013-03-27 CN disclosed